Literature DB >> 11425269

Comparative analysis of two-dimensional protein patterns in malignant and normal human breast tissue.

K F Czerwenka1, M Manavi, J Hosmann, D Jelincic, K I Pischinger, W B Battistutti, M Behnam, E Kubista.   

Abstract

Malignant and normal human breast tissue were compared by evaluating two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) maps of frozen tissue samples. Image analyzing software was used to scan and process 34 gels. Eight (8/34) of these gels (4 malignant breast tumor samples, 4 normal tissue samples) were selected on the basis of gel and image quality to build a database to identify and measure the expression of a previously unidentified proteome. Growth factor receptor proteins (GFRs), including ERBB2 (HER2) and ERBB3 (HER3), were expressed in the malignant tissue samples. Growth factor receptor proteins were not expressed in the normal tissue. Also, expression of PS2-protein (pS2) was detected in neither malignant nor normal tissue. In benign breast samples a higher intensity of protein expression could be observed for maspin, desmoglein 3 and keratin 8 than in malignant samples. Other proteins expressed in malignant breast tissue include mitogen-activated protein kinase 3 (MK03), heat shock protein 27 kDa (HS27), growth factor receptor-bound protein (GRB2), cathepsin D, G1/S specific cyclin E1 (CGEI), glucose transporter type 5 (GTR5), and a number of as yet unidentified proteins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11425269

Source DB:  PubMed          Journal:  Cancer Detect Prev        ISSN: 0361-090X


  8 in total

Review 1.  Current perspectives in cancer proteomics.

Authors:  Miriam V Dwek; Sarah L Rawlings
Journal:  Mol Biotechnol       Date:  2002-10       Impact factor: 2.695

Review 2.  Proteomic dissection of dome formation in a mammary cell line.

Authors:  I Zucchi; R Dulbecco
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-10       Impact factor: 2.673

Review 3.  The ERBB3 receptor in cancer and cancer gene therapy.

Authors:  G Sithanandam; L M Anderson
Journal:  Cancer Gene Ther       Date:  2008-04-11       Impact factor: 5.987

4.  Nuclear, compared with combined nuclear and cytoplasmic expression of maspin, is linked in lung adenocarcinoma to reduced VEGF-A levels and in Stage I, improved survival.

Authors:  Amy Frey; Ayman O Soubani; Abdulgadir K Adam; Shijie Sheng; Harvey I Pass; Fulvio Lonardo
Journal:  Histopathology       Date:  2009-03-20       Impact factor: 5.087

5.  Maspin expression in epithelial skin tumours: an immunohistochemical study.

Authors:  Asmaa Gaber Abdou; Alaa Hassan Maraee; Mohamed Abd El-Monaem Shoeib; Amany Mohamed Abo Saida
Journal:  J Cutan Aesthet Surg       Date:  2011-05

6.  Proteomic analysis of nipple aspirate fluid to detect biologic markers of breast cancer.

Authors:  Edward R Sauter; W Zhu; X-J Fan; R P Wassell; I Chervoneva; G C Du Bois
Journal:  Br J Cancer       Date:  2002-05-06       Impact factor: 7.640

Review 7.  The diagnosis and management of pre-invasive breast disease: promise of new technologies in understanding pre-invasive breast lesions.

Authors:  Stefanie S Jeffrey; Jonathan R Pollack
Journal:  Breast Cancer Res       Date:  2003-10-09       Impact factor: 6.466

8.  New insights into phenotypic heterogeneity for the distinct lipid accumulation of Schizochytrium sp. H016.

Authors:  Zhendong Bao; Yuanmin Zhu; Kai Zhang; Yumei Feng; Meng Zhang; Ruili Li; Longjiang Yu
Journal:  Biotechnol Biofuels Bioprod       Date:  2022-03-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.